Fixed Combination for the Treatment of Dyslipidaemia

被引：0
|
作者：
Nicola Ferri
Massimiliano Ruscica
Raul D. Santos
Alberto Corsini
机构：
[1] University of Padova,Department of Medicine (DIMED)
[2] Veneto Institute of Molecular Medicine (VIMM),Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti”
[3] University of Milan,Lipid Clinic, Heart Institute (InCor)
[4] Department of Cardio-Thoracic-Vascular Diseases – Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico,undefined
[5] University of São Paulo,undefined
[6] Hospital Israelita Albert Einstein,undefined
来源：
Current Atherosclerosis Reports | 2023年 / 25卷
关键词：
Statins; Bempedoic acid; Ezetimibe; Fenofibrate; Combinations; Polypill;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 699
页数：8
相关论文
共 50 条
  • [21] A fixed-dose combination treatment strategy to reduce premature cardiovascular disease deaths globally
    Liuzzo, Giovanna
    Patrono, Carlo
    EUROPEAN HEART JOURNAL, 2022, 43 (01) : 16 - 17
  • [22] Evaluating the efficacy and safety of atorvastatin plus ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia
    Ma, Ya-Bin
    Chan, Paul
    Zhang, Yuzhen
    Tomlinson, Brian
    Liu, Zhongmin
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (08) : 917 - 928
  • [23] FenofibrateA Review of its Use in Dyslipidaemia
    Kate McKeage
    Gillian M. Keating
    Drugs, 2011, 71 : 1917 - 1946
  • [24] Micronised fenofibrate: A convenient once-daily formulation for the treatment of dyslipidaemia
    不详
    Drugs & Therapy Perspectives, 1998, 11 (6) : 1 - 5
  • [25] Current treatment of dyslipidaemia: PCSK9 inhibitors and statin intolerance
    Koskinas, Konstantinos C.
    Wilhelm, Matthias
    Windecker, Stephan
    SWISS MEDICAL WEEKLY, 2016, 146 : w14333
  • [26] Correlation between dyslipidaemia and gastric cancer: pathogenesis to prevention and treatment strategies
    Tao Wu
    Lingna Zhang
    Jiao Tian
    Yuyuan Lu
    Yan Yang
    Xin Yang
    Penghui Jin
    Yuanhui Gu
    Xiaoke Wang
    Lin Yi
    Lipids in Health and Disease, 24 (1)
  • [27] A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy
    Aguiar, Carlos
    Alegria, Eduardo
    Bonadonna, Riccardo C.
    Catapano, Alberico L.
    Cosentino, Francesco
    Elisaf, Moses
    Farnier, Michel
    Ferrieres, Jean
    Filardi, Pasquale Perrone
    Hancu, Nicolae
    Kayikcioglu, Meral
    Mello e Silva, Alberto
    Millan, Jesus
    Reiner, Zeljko
    Tokgozoglu, Lale
    Valensi, Paul
    Viigimaa, Margus
    Vrablik, Michal
    Zambon, Alberto
    Luis Zamorano, Jose
    Ferrari, Roberto
    ATHEROSCLEROSIS SUPPLEMENTS, 2015, 19 : 1 - 12
  • [28] Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins
    Negredo, Eugenia
    Molto, Jose
    Puig, Jordi
    Cinquegrana, Denise
    Bonjoch, Anna
    Perez-Alvarez, Nuria
    Lopez-Blazquez, Raquel
    Blanco, Asuncion
    Clotet, Bonaventura
    Rey-Joly, Celestino
    AIDS, 2006, 20 (17) : 2159 - 2164
  • [29] Combination drug treatment in obese diabetic patients
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    WORLD JOURNAL OF DIABETES, 2010, 1 (01): : 8 - 11
  • [30] The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
    Nodari, Savina
    Rocca, Patrizia
    Saporetti, Alberto
    Bettari, Luca
    Foresti, Anna Lucia
    Tanghetti, Elena
    Metra, Marco
    Cas, Livio Dei
    HEART INTERNATIONAL, 2007, 3 (1-2): : 12 - 17
12345